- Home
- PAC vs RVTY Comparison
PAC vs RVTY Comparison
Compare PAC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAC | RVTY |
|---|---|---|
| Founded | 1998 | 1937 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 11.8B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | PAC | RVTY |
|---|---|---|
| Price | $232.72 | $85.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | ★ $270.00 | $113.00 |
| AVG Volume (30 Days) | 90.1K | ★ 1.0M |
| Earning Date | 04-27-2026 | 04-27-2026 |
| Dividend Yield | ★ 4.83% | 0.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $40.63 | $6.34 |
| Revenue Next Year | $10.68 | $5.10 |
| P/E Ratio | ★ $27.29 | $41.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $168.62 | $81.36 |
| 52 Week High | $300.41 | $118.30 |
Technical Indicators
Market Signals| Indicator | PAC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 35.91 | 31.33 |
| Support Level | $211.42 | $82.98 |
| Resistance Level | $239.33 | $95.44 |
| Average True Range (ATR) | 9.20 | 3.01 |
| MACD | -1.55 | -0.66 |
| Stochastic Oscillator | 19.83 | 10.39 |
Price Performance
Historical ComparisonAbout PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.